China Universal Asset Management Company’s BioAge Labs BIOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$173K Sell
7,075
-632
-8% -$11.4K 0.01% 367
2026
Q1
$135K Buy
7,707
+1,864
+32% +$35.9K 0.01% 383
2025
Q4
$77.3K Buy
+5,843
New +$51.8K 0.01% 423

Other funds holding BIOA

China Universal Asset Management Company's BIOA Position: Q2 2026 in Review

China Universal Asset Management Company reduced its BioAge Labs (BIOA) stake by 8.2% in Q2 2026, selling an estimated $11.4K and leaving 7,075 shares worth $173K. The position accounts for 0.01% of the portfolio, ranked #367.

China Universal Asset Management Company first reported a position in BIOA in Q4 2025 and has held it in 3 quarters since. 65 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • China Universal Asset Management Company held 7,075 shares of BioAge Labs worth $173K as of Q2 2026.
  • China Universal Asset Management Company sold 632 BioAge Labs shares in Q2 2026, an estimated $11.4K.
  • BioAge Labs made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #367 holding.
  • China Universal Asset Management Company first reported a position in BioAge Labs in Q4 2025 and has held it in 3 quarters since.
  • 65 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.